THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ innovative new assay to detect marijuana, or cannabis, use. Using high-resolution, tandem mass spectrometry, our test identifies metabolites of both delta-9- tetrahydrocan
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31):
Before we get started, can you tell us a little bit about yourselves and your backgrounds?
(02:35):
Can you guys give us a brief overview of this assay and what will be changing to characterize marijuana use?
(04:28):
So which patients should have this testing and when would you say it should be performed, Dr. Langman?
(05:58):
Are there other test options available and if, and if so, how do these compare?
(07:03):
This is really the best way to accurately characterize marijuana use. Would you say that's true?
(07:11):
And then could you, Dr. Langman, explain how the results are used in patient care?